Instent CTO-What Is the Best Treatment Strategy? | Cardiovasc Drugs Ther;38(3): 393-394, 2024 Jun. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL CLAP/WR-PAHO/WHO

Latin-American Center for Perinatology, Woman and Reproductive Health

Subject descriptor lookup Advanced Search

Instent CTO-What Is the Best Treatment Strategy?

Sahyouni, Mark; Stouffer, George A.

Affiliation

Sahyouni M; Campbell University School of Osteopathic Medicine, Lillington, NC, 27546, USA.
Stouffer GA; Division of Cardiology and McAllister Heart Institute, University of North Carolina, Chapel Hill, NC, 27599-7075, USA. rstouff@med.unc.edu.

Cardiovasc Drugs Ther ; 38(3): 393-394, 2024 Jun.

Article in En | MEDLINE | ID: mdl-38270692

Subject(s)

Coronary Occlusion; Humans; Coronary Occlusion/therapy; Percutaneous Coronary Intervention; Treatment Outcome

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Occlusion Limits: Humans Language: En Journal: Cardiovasc Drugs Ther Journal subject: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Type: Article Affiliation country: United States

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Coronary Occlusion Limits: Humans Language: En Journal: Cardiovasc Drugs Ther Journal subject: ANGIOLOGIA / CARDIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2024 Type: Article Affiliation country: United States